Abstract Background: In early stages of septic shock, impaired myocardial function plays an important prognostic role. AEF and Plasma BNP level may be a valuable prognostic factor for patients with sepsis.
Introduction
Sepsis is defined as ''the systemic inflammatory response syndrome (SIRS) that occurs during infection.''Sepsis is not a homogenous disease; rather, it is a complex clinical syndrome with distinct immunological features [1, 2] . The ambiguities of clinical findings and unclear risk stratification in sepsis have been major problems in sepsis intervention trials [3] .
In early stages of septic shock, impaired myocardial function plays an important prognostic role. In this context, B-type natriuretic peptide (BNP) has been shown to be a neurohumoral marker for left ventricular dysfunction, because myocardial strain and ischemia both increase BNP concentration [4] Ventricular dysfunction with reduced ejection fraction and biventricular dilatation is present in most patients with severe sepsis and septic shock. In survivors, this depression in cardiac function is reversible over the course of seven to ten days. Even though some prognostic factors have been identified in patients with sepsis-induced myocardial dysfunction, their measurement often includes costly and cumbersome techniques. Thus, there is a need for an inexpensive, simple, rapid, and readily available marker to predict mortality in septic shock. There is a growing evidence supporting the hypothesis that BNP could be an early predictor of mortality in septic shock. If proven, the hypothesis would have important clinical and public health implications [5] . Plasma BNP level may be a valuable prognostic factor for severe sepsis and septic shock patients [6] .
There have been many studies in animals and a few in humans which have confirmed the presence of diastolic dysfunction -particularly in those patients that go on to die from sepsis. In the presence of adequate fluid resuscitation there is an increase in end diastolic volume and this is probably a normal response to a decrease in contractility. However, in the non-survivors of sepsis there is a normal or low-end diastolic volume that is the result of a decrease in ventricular diastolic compliance. Thus, there is a decreased end diastolic volume at the same filling pressure [7] .
Assessment of diastolic function through measurement of the components of ventricular filling has largely neglected the vigor of atrial systole, in part because this has been difficult to quantify. However, atrial ejection force defined as the force exerted by the left atrium to accelerate blood into the left ventricle during atrial systole can be assessed non-invasively by combined two-dimensional imaging and Doppler echocardiography. This index of atrial function, based on classic Newtonian mechanics, provides a physiologic assessment of atrial systolic function [8] .
The aim of this work
Is to assess the utility of atrial function (diagnosed by atrial ejection force) in predicting mortality in the ICU population with sepsis. Our hypothesis was that as the atrium shares the same pathophysiological effects as the ventricles, assessment of the atrial function may be used as an alternative easy method of assessing the severity of myocardial dysfunction in sepsis and may therefore help to predict mortality. We aimed also to evaluate the value of B-type natriuretic peptide (BNP) in predicting the outcome of sepsis, severe sepsis, and septic shock patients.
Patients and methods
This was a prospective study involving forty patients with sepsis admitted to the intensive care unit in the Theodor Bilharz research institute (TBRI) from March 2012 to September 2013. This study was approved by the local ethics committee and an informed consent was obtained from every patient or his next of kin if the patient was unable to give consent before being included in the study.
Inclusion criteria
Patients with 1-Sepsis: Documented or suspected infection associated with Systemic inflammatory response syndrome (SIRS) when two or more of the following criteria are met:
A. Body temperature >38°C or <36°C. B. Tachycardia >90/minute. C. Hyperventilation: respiratory rate >20/minute or arterial hypocapnia <32 mmHg. D. White blood cell count >12,000/dL or <4000/dL or immature forms >10%.
2-Severe sepsis: Sepsis associated with organ dysfunction. 3-Septic shock: Sepsis associated with circulatory failure characterized by persistent arterial hypotension (decreased systolic blood pressure below 90 mmHg or P40 mmHg from baseline, or mean arterial pressure <60 mmHg despite adequate fluid resuscitation) unexplained by other causes [9] . Included patients were subjected to the following:
Written consent (by the patient or his relatives). History. Full clinical assessment. Laboratory tests on admission and follow up including cultures as appropriate. Acute physiology and chronic health evaluation II (APACHE II) scores and the length of stay (LOS) in ICU were collected. Plasma BNP level (by Enzyme Immunoassay (EIA)) was measured upon admission and on the third day after admission to the intensive care unit. Transthoracic echocardiography (TTE): All echocardiographic measurements were performed by one operator and according to the recommendations of the American Society of Echocardiography [10] . M-mode, two-dimensional echocardiography, and doppler ultrasound studies were made using a high-resolution (ALT 5000 HDI) Toshiba Nemo 30 scanner equipped with a 2.5 mHz transducer. With M-mode, measurements of interventricular septum (IVS) and left ventricle posterior wall thicknesses (PWT) separately at diastole and systole were done and left ventricle end-diastolic (LVEDD) and end systolic (LVESD) diameters were determined. Left ventricular ejection fraction (EF%) was measured from M-mode dimensions using Teichholz formula [11] .
Left atrium diameter was determined from the parasternal long axis view at end systole. Left atrium volume was measured with Simpson's method using apical 4-chamber and apical 2-chamber views at the ventricular end systole (maximum LA size). Estimation of LA volume by Simpson's method of disk is well validated and recommended by the American Society of Echocardiography (ASE) guidelines [12] . Mitral valve diameter (MVD) was measured manually from a four-chamber view using two-dimensional echocardiography. Mitral valve area (MVA) was calculated as 3.14(MVD/2) 2 on the assumption that the mitral valve orifice is circular. Sample volume was placed at the mitral annulus level and A waves were recorded from a four-chamber view at a paper speed of 50 mm/s using pulsed-Doppler echocardiography. The peak velocity of A waves was obtained from averaging three consecutive beats.
Atrial ejection force was estimated using the following equation:
Atrial ejection force ¼ mass Â acceleration; substituting for mass and acceleration;
Atrial ejection force
The unit of force would thus be measured in g-cm/s À2 or dynes [13] .
One of the difficulties that faced us during the study is measurement of the density of the blood because it may change with sepsis; finally we decided to set the blood density at 1.06 g/cm 3 (normal range), which the other studies stated to be comparable to their results. All echocardiographic measurements were done on the first day of admission and on the third day. Because the mean of the length of stay in our ICU in the year before the study was 3 days, we decided to follow up the Echo and BNP in the third day. Other data collected included the requirements for mechanical ventilation (ventilation hours) and vasopressor and the patient's outcome (survived or not survived).
All collected questionnaires were revised for completeness and consistency. Pre-coded data were entered on the computer using ''Microsoft Office Excel Software'' program (2010) for windows. Data were then transferred to the Statistical Package of Social Science Software program, version 16 (SPSS) to be statistically analyzed. Data were summarized using mean, standard deviation, median and percentiles for quantitative variables and frequency and percentage for qualitative ones.
Comparison between groups was done using independent sample t-test and one way ANOVA (if parametric) and Mann Whitney test and Chi square test or Fischer exact test for qualitative ones. Pearson correlation coefficient was calculated to get the association between different quantitative variables. Discriminate analysis was conducted through receiver operating characteristics (ROC) analysis. P values equal to or less than 0.05 were considered statistically significant. 
Results
We studied 40 patients: 17 had sepsis, 14 had severe sepsis, and nine had septic shock during the study. We used the criteria of the 2001 SCCM/ESICM/ACCP/ATS [9] international sepsis definitions conference to define and classify the patients. In our study, 17 patients did not survive while 23 patients survived. There was no statistically significant difference between the two groups concerning age and the gender.
The two compared groups were homogenous. In our study, 21% of survivors and 94% of non-survivors were mechanically ventilated. In our study, 13% of survivors and 88% of non-survivors were on vasopressors; we used Norepinephrine as the first choice vasopressor (grade 1B) (SSc2012) [14] (see Tables  1-7 ).
Logistic regression analysis
It was done to search for the significant predictors of mortality in sepsis BNP on the first and third day; EF first and third day and AEF third day were entered in the logistic regression analysis and BNP third day was found to be a significant predictor for mortality in patients with sepsis (p-value was 0.001).
ROC curve for the predictors of mortality in patients with sepsis
We found that a BNP first day level of 449 pg/ml can signify a sensitivity of 94% and a specificity of 79% in predicting the mortality of patients presenting with sepsis, severe sepsis, and septic shock while a BNP third day level of 544 pg/ml can signify a sensitivity of 82% and a specificity of 92% in predicting the mortality of patients presenting with sepsis, severe sepsis, and septic shock. An AEF third day level of 9.8Kdyn can signify a sensitivity of 91% and a specificity of 89% in predicting the survival of patients presenting with sepsis, severe sepsis, and septic shock (see Figs. 1 and 2 ).
Discussion

Atrial ejection force (AEF) and sepsis
Determination of the left atrial systolic functions by measuring atrial ejection force (AEF) at the left ventricle relaxation enables us to assess atrial contribution to the left ventricle filling, thus AEF serves equally as an indirect parameter of the left ventricle diastolic functions to assess left ventricle relaxation.
Regarding the importance of age as an influencing factor for AEF measurements, we do not believe there is a statistically significant difference in the mean age of our patients in comparison with patients in other comparable studies. The age ranged from 20 to 82 years with a mean age of 52.9 ± 15 years, and this was slightly higher than that observed in Omar et al. [15] in which the mean age was 49 ± 16 years.
In the current study, there was a statistically insignificant association between AEF measured on the first day and mortality admission; AEF was higher in the group of survivors than in non-survivors.
To our knowledge, only one study by Omar et al. [15] explored the left atrial function in sepsis. Our results are in agreement with this study that found a statistically insignificant association between the left atrial ejection fraction and the mortality in such patients and concluded that it cannot be used as an outcome predictor. Omar et al. [15] also found that AEF was slightly higher in the survivors compared to non survivors. Their hypothesis was that serial AEF may predict survival in patients with septic shock. In our study, AEF on the third day showed a statistically significant decrease in the non-survived group (p = 0.000) Table 6 Relation between AEF in first and third day in non survivors and survivors. and a statistically significant increase in the survived group (p = 0.000) in comparison with that measured on the first day. Omar et al. [15] also found that AEF increased in the survived group and decreased in the non-survived group on the fourth day of admission in comparison with the first day.
No studies have compared the results of AEF on the third day and mortality; we found a statistically significant difference in AEF measured on the third day between survivors and non-survivors, which was 8.4 ± 1 k dynes and 11.6 ± 1.6 k dynes, respectively (P = 0.0001). There was a statistically significant negative association between the APACHE II scores AEF 3rd day (R = À0.508, P = 0.001).
Our study also found a negative correlation between AEF measured on the third day and BNP measured on the third day (P = 0.001).
The receiver operating characteristic curve demonstrated that an AEF third day level of 9.8Kdyn can signify a sensitivity of 91% and a specificity of 89% in predicting the survival of patients presenting with sepsis, severe sepsis, and septic shock. (Area under curve for AEF third day is 0.97).
Brain natriuretic peptide BNP in patients with sepsis
The role of the BNP as a diagnostic test of heart failure was extensively explored in the recent years. In 2002, Maisel et al. [16] performed a large multicenter investigation involving 1586 patients who presented to an emergency department (ED) with acute dyspnea. They found that a serum BNP level is useful to assist in differentiating between heart failure and pulmonary disease as a cause of dyspnea. In this study, a BNP level of 100 pg/ml or higher was 90% sensitive and 73% specific for diagnosing congestive heart failure (CHF).
In our study, we decided to measure the BNP because it is a more reliable measurement in renal failure patients (a common finding in critically ill septic patients) than NT--pro BNP--as shown by DeFilippi et al. [17] who concluded in their review that the NT-proBNP rises disproportionately to BNP at lower estimated glomerular filtration rate (eGFR).
In our study, survivors had a significantly lower BNP level (mean value of 326.01 ± 199.07 pg/ml) than the non-survivors (mean value of 622.25 ± 157.45 pg/ml) on admission (p = 0.0001) and also on the third day of admission, the BNP in non-survivors (mean value of 802.81 ± 256.04) pg/ ml group was statistically higher than the survivors group (mean value of 289.97 ± 80.39 pg/ml) (p = 0.0001).
The results of our study are in agreement with other studies concerning the role of BNP in septic patients. Abu-Khabar et al. [18] found BNP in survivors on admission ranged between 80 and 936 with a mean value of 345.01 ± 222.1 pg/ ml. This remained stable during day 1, 2 and 3 but decreased on discharge. In non-survivors BNP ranged between 145 and 1210 pg/ml with a mean of 708.62 ± 305.17 pg/ml on admission and changed significantly during the study period. The mean level decreased on day 1 then increased in day 2 and 3. Survivors had a significantly lower BNP level than the nonsurvivors on admission and at all three intervals. Also in Omar et al. [15] the authors found that admission BNP concentrations were significantly higher in the non-survivors (P < 0.0001).
Zhang et al. [19] recently showed that elevated baseline BNP was associated with significantly increased risk of mortality. The association of elevated baseline BNP with increased risk of mortality has been proven in multiple studies [20, 21] . This association may be attributable to sepsis-related cardiac depression that is characterized by myocardial stiffness and mechanical insufficiency. In response to myocardial stretch, the plasma BNP level will increase [19] .
Cuthbertson et al. [22] showed that there was a trend toward higher BNP levels on ICU admission and at 24 h in survivors. Although this is not in agreement with our study, the trend was not statistically significant in his study.
Sturgess et al. [23] found levels of BNP, of 448 ± 607 pg/ml and 1289 ± 1155 pg/ml in survivors and non-survivors respectively, but the difference was not statistically significant. The difference in the values of the BNP in the different studies could be explained by the different kits of analysis with different sensitivity. The non-significance in the last study may also be attributed to the small number of patients included (n = 21).
Brain natriuretic peptide BNP changes during time
In our study, we calculated the sensitivity and specificity of the BNP on the first day; we found that a level of 449 pg/ml had a sensitivity of 94% and a specificity of 79% in predicting the mortality of patients presenting with sepsis, severe sepsis, and septic shock. While a BNP third day level of 544 pg/ml had a sensitivity of 82% and a specificity of 92% in predicting the mortality of patients presenting with sepsis, severe sepsis, and septic shock, this means that the BNP on the first day was more sensitive but less specific than its level on the third day. While in Abu-Khabar et al. [18] Operating Characteristic curve showed that a BNP level of 250.5 had a sensitivity of 82.8% and a specificity of 64.7% in predicting the mortality of patients presenting with severe sepsis and septic shock.
Brain natriuretic peptide BNP and age
Regarding the importance of the age as an influencing factor for the BNP measurements, we cannot consider that there is a statistically significant difference in the mean age of our patients in comparison with patients in other comparable studies. The age ranged from 20 to 82 years with a mean age of 52.9 ± 15 years, which was slightly lower than that observed in the studies concerning the epidemiological data of patients with severe sepsis including that of Brueckmannet al. [24] with a mean age of the enrolled patients at 55.0 ± 16.3 years. In Abu-Khabar et al. [18] the age ranged from 26 to 79 years with a mean age of 60.1 ± 13.3 years.
In our study, we found a statistically significant association between the degree of sepsis and BNP serum level on both the first day and the third day. There are many studies that relate BNP levels to the degree of sepsis and septic shock, and these studies mainly focused on hospitalized patients in the intensive care unit [25] .
Rivers et al. [26] found that the BNP in septic shock patients in the emergency department occurred at higher rates than in patients with sepsis.
In the current study, we found a statistically significant rise in BNP in the non-survival group from day 1 to day 3 (p = 0.002) and a statistically significant decrease from day 1 to day 3 in the survived group (p = 0.001). Abu-Khabar et al. [18] also found a statistically significant rise in BNP in the non-survival group from day 1 to day 3 (p = 0.001) and also found a statistically significant BNP decrease from day 1 to the time of discharge in the survived group (p = 0.001). This is in agreement with Omar et al. [15] results, where BNP was significantly higher in the non-survivors (P < 0.0001) and remains significantly higher on the fourth and seventh days (P = 0.01 and 0.001, respectively, in the non-survivors). BNP tends to decrease throughout the course in survivors (592 on day 1, 318 on day 4, and 93 pg/ml on day 7).
Limitations
Limitation of the study was the relatively small sample size and the Effect of mechanical ventilation, vasopressors and other medications on AEF is not known. Further studies are needed.
Conclusion
Atrial ejection force on the first day of admission, unlike BNP level, might not be used as an independent predictor of mortality in patients with sepsis. BNP level correlates with the severity of sepsis. According to our study, AEF in the third day may be a good predictor for survival of patients presenting with sepsis.
